Shanghai New Hongqiao International Medical Park

Shanghai New Hongqiao International Medical Center, also referred to in English as Shanghai New Hongqiao International Medical Park, is a Shanghai-based healthcare infrastructure and medical services ecosystem rather than a drug-development biotech company. The core operating entity appears to be Shanghai Hongqiao International Medical Center Construction and Development, a state-owned company founded in 2011 that develops, invests in, and manages facilities within the medical center. The organization focuses on building and operating a large medical campus that hosts hospitals, specialty clinics, medical technology platforms, and related support services in Shanghai's Minhang District. Public descriptions position it as a pilot zone for medical reform and a hub for premium healthcare delivery, medical technology, and health-industry investment. It does not appear to have a proprietary therapeutic pipeline, disclosed drug candidates, or identified molecular targets in the way a biotech or pharma company would.